Medical Products Supplies Companies

3661 Horseblock Road, 11763 Medford, NY
USA
Telephone +1 631 924-1135
customerservice@chembio.com
http://www.chembio.com

Product Categories

Product categories

03 Diagnostic Tests
03.02 Immunochemistry testing, immunology testing
03.02.02 Diagnostic rapid tests

Diagnostic rapid tests

DPP® HIV 1/2 Assay
DPP® HIV-Syphilis Assay
HIV 1/2 STAT-PAK® Assay
HIV 1/2 STAT-PAK® DIPSTICK Assay
STAT-VIEW® HIV 1/2 Assay (CE Marked)
DPP® Syphilis Screen & Confirm Assay (CE Marked)
DPP® Zika IgM/IgG System (CE-Marked)
DPP® Zika IgM System

Our products

Product category: Diagnostic rapid tests
DPP® HIV 1/2 Assay
Chembio has developed a NEXT GENERATION DPP® assay using patented DPP® technology for the rapid detection of HIV 1 and HIV 2 antibodies in oral fluid and all blood matrices. The Chembio DPP® HIV 1/2 Assay is intended for use as a point-of-care test to aid in the diagnosis of infection with HIV 1 and HIV 2. This test is suitable for use in multi-test algorithms that have been established in many countries or as a standalone initial test.

Product category: Diagnostic rapid tests
DPP® HIV-Syphilis Assay
Chembio Diagnostic Systems has developed the first dual HIV 1/2 and Syphilis Point-of-Care (POC) test utilizing Chembio’s patented Dual Path Platform (DPP®) technology. The Chembio DPP® HIV-Syphilis Assay is a single-use, immunochromatographic, rapid test for the detection of antibodies to Human Immunodeficiency Virus Types 1 and 2 (HIV 1/2) and Treponema pallidum (the causative agent of syphilis) in fingerstick whole blood, venous whole blood, serum, and plasma.

The Chembio DPP® HIV-Syphilis Assay is intended for use as a point-of-care test to aid in the diagnosis of infection with HIV and/or Syphilis. This test is suitable for use in multi-test algorithms designed for the statistical validation of rapid HIV test results.

A unique feature of this kit is Chembio’s new DPP® SampleTainer® bottle which contains a premeasured dilution buffer within a closed vial that also serves as a dropper for performing the assay. Smart, easy and efficient!

Product category: Diagnostic rapid tests
HIV 1/2 STAT-PAK® Assay
Chembio HIV 1/2 STAT-PAK® tests are easy-to-perform, single-use diagnostic tests for the rapid (15 minutes), visual detection of antibodies to HIV 1 and HIV 2 at point-of-care (POC).

For Use With:

Serum
Plasma
Fingerstick whole blood
Venipuncture whole Blood

Product category: Diagnostic rapid tests
HIV 1/2 STAT-PAK® DIPSTICK Assay
HIV 1/2 STAT-PAK® DIPSTICK tests are easy-to-perform, single-use diagnostic tests for the rapid, visual detection of antibodies to HIV 1 and HIV 2.

For Use With:

Serum
Plasma
Fingerstick
Venipuncture whole blood

Product category: Diagnostic rapid tests
STAT-VIEW® HIV 1/2 Assay (CE Marked)
Chembio’s STAT-VIEW® HIV 1/2 Assay is a unique, easy-to-use, self-contained, single-use collection and testing device for the rapid, visual detection of antibodies to HIV 1 and HIV

For Use With:

Serum
Plasma
Fingerstick
Venipuncture Whole Blood

Product category: Diagnostic rapid tests
DPP® Syphilis Screen & Confirm Assay (CE Marked)
A rapid point-of-care test that simultaneously and separately detects treponemal and nontreponemal antibodies.

Key Features

Innovative: Screen and confirm syphilis infection simultaneously, no need for reflex testing
Simple to use: Does not require specialized medical training
Actionable: Provides results in as little as 15 minutes, enabling physicians to make treatment decisions
Cost effective: Reduces overtreatment rate and cost burden; eliminates repeated visits to healthcare professionals

Product category: Diagnostic rapid tests
DPP® Zika IgM/IgG System (CE-Marked)
Single-use point-of-care (POC) assays for use with reader for the discrete, semi-quantitative detection of Immunoglobulin M (IgM) and Immunoglobulin G (IgG) antibodies to Zika Virus.

For Use With:

Serum
Plasma
Fingerstick whole blood
Venipuncture whole blood

Product category: Diagnostic rapid tests
DPP® Zika IgM System
For the detection of Zika virus IgM antibodies in fingerstick whole blood, EDTA venous whole blood, EDTA plasma and serum

Key features

Fast: Provides results in as little as 15 minutes
Flexible: Detects Zika virus IgM antibodies from 8 days up to 12 weeks
Easy to use: Provides objective results using simple, handheld digital reader (DPP® Micro Reader)

Product performance
Wide testing window
DPP® Zika IgM Assay System detected Zika antibodies as early as day 8 and reliably detected for approximately 12 weeks1

ad: contact information

About Us

Company details
We Improve Lives—that’s what drives us. It’s what makes us better, more innovative, more compelled to work harder. What we do is develop superior point-of-care rapid testing solutions for healthcare providers around the world; what we help create is healthier lives and communities.

Our Products meet the highest standards for accuracy and superior performance to help prevent the spread of infectious diseases. Our innovative solutions, like the Chembio Dual Path Platform (DPP®), make POC testing faster, more accurate, and more cost effective. And all of Chembio’s products have been designed, developed, tested, and manufactured in our Medford, NY, USA facility.

Our People—are what makes Chembio. Chembio has a solid core of loyal, experienced, professional employees, and that creates loyal customers.
These are our values.

ad: company